Cargando…
Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
Autores principales: | Greco, Raffaella, Peccatori, Jacopo, Bonifazi, Francesca, Snowden, John A., Ciceri, Fabio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994590/ https://www.ncbi.nlm.nih.gov/pubmed/33777058 http://dx.doi.org/10.3389/fimmu.2021.670822 |
Ejemplares similares
-
Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties
por: Greco, Raffaella, et al.
Publicado: (2019) -
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide
por: Greco, Raffaella, et al.
Publicado: (2019) -
Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications
por: Annaloro, Claudio, et al.
Publicado: (2021) -
Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells
por: Bacchetta, Rosa, et al.
Publicado: (2014) -
Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC)
por: Bregni, Marco, et al.
Publicado: (2011)